Abstract
Even though the roles of different known or suggested prognostic factors in laryngeal cancer have been studied in detail, clinical stage at time of diagnosis and anatomic subsite of the tumour remain the only practical predictors of clinical outcome and offer the only guidelines in the planning of treatment. In this study, the relative roles of known demographic and clinical prognostic factors, in addition to four histopathological factors, were evaluated in a sample of 100 laryngeal carcinoma patients with multivariate analysis using the Cox regression model. In addition to advanced stage (stage III-IV) (relative hazard of death (HR) 8.9, p=0.01) and supraglottic disease (HR 5.6, p=0.02), high apoptotic index (HR 11.1, p=0.05) was significantly associated with poor survival. Cell proliferation, p53 and angiogenesis did not significantly affect the prognosis. In the future, high degree of apoptosis could be used to identify patients with poor prognosis in laryngeal cancer.
References
Nov 1, 1991·Histopathology·G WiernikJ L Haybittle
Oct 1, 1991·Journal of Surgical Oncology·L P KowalskiP L Pontes
Aug 15, 1986·Cancer·E PeraL Galindo
Jan 1, 1980·International Review of Cytology·A H WyllieA R Currie
Feb 1, 1995·Clinical Otolaryngology and Allied Sciences·M A SalamA Morris
Jan 26, 1996·International Journal of Cancer. Journal International Du Cancer·P CrosignaniF Berrino
Jun 1, 1996·Archives of Otolaryngology--head & Neck Surgery·M F SpaffordW A Franklin
May 1, 1997·Head & Neck·D AgudeloJ Burgués
Jun 1, 1997·Archives of Otolaryngology--head & Neck Surgery·C R BradfordG T Wolf
Jun 15, 1997·American Journal of Epidemiology·P BoffettaB Terracini
Sep 19, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P HirvikoskiV M Kosma
Jan 24, 1998·Archives of Otolaryngology--head & Neck Surgery·P U HegdeJ S Coon
Jan 28, 1998·Cancer·A NarayanaS P Reddy
May 1, 1998·Clinical Otolaryngology and Allied Sciences·H RowleyA S Jones
Jan 13, 1999·Clinical Otolaryngology and Allied Sciences·T KrecickiT Szkudlarek
Mar 5, 1999·Cellular and Molecular Life Sciences : CMLS·S Bates, K H Vousden
Apr 20, 1999·Archives of Otolaryngology--head & Neck Surgery·M A HotzM M Borner
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P HirvikoskiV M Kosma
Apr 14, 2000·Clinical Otolaryngology and Allied Sciences·J GreenmanN D Stafford
Aug 16, 2000·Clinical Otolaryngology and Allied Sciences·J J HomerN D Stafford
Jan 6, 2001·Acta histochemica·B SikorskaM Danilewicz
May 10, 2001·Current Opinion in Cell Biology·K M RyanK H Vousden
Jun 16, 2001·Head & Neck·M FriedmanJ S Coon
Jun 16, 2001·Head & Neck·B BrennerE Rakowsky
Jan 22, 2002·The Laryngoscope·P LavertuM Secic
Feb 28, 2002·Acta Oncologica·H TeppoO P Alho
Citations
Sep 24, 2010·Medical Oncology·Da-Wei LiPin Dong
Jul 21, 2005·Journal of the National Cancer Institute·Panayiotis A KyzasJohn P A Ioannidis
Apr 17, 2008·BMC Genomics·Jack Y YangXudong Huang
Oct 2, 2007·European Journal of Nuclear Medicine and Molecular Imaging·David LooseChristophe Van de Wiele
Nov 15, 2005·Head & Neck·Phillipe LothaireAhmad Awada
Jun 4, 2014·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Federico Maria GioacchiniMassimo Re
Jan 27, 2015·Brazilian Journal of Otorhinolaryngology·Christiana Vargas RibeiroJosé de Souza Andrade Filho
Jan 28, 2012·The Annals of Otology, Rhinology, and Laryngology·Bin ShenShang Gao
Mar 11, 2018·BMC Cancer·Anke SchlüterSven Brandau
Nov 13, 2013·Cancers·Frédéric L W V J Schaper, Chris P Reutelingsperger
Oct 6, 2016·Oncology Letters·Yanxia BaiShengli Wu
Feb 16, 2019·BioMed Research International·J VukelicT Braut
Oct 17, 2020·Disease Markers·Yanbo DongLiangfa Liu